This video, filmed at
the INR® in Los Angeles during 2008, documents the many improvements
sustained through the first year of treatment with perispinal
etanercept (PSE) in a patient with severe, early onset dementia,
as related by the patient's wife. Please see
Perispinal etanercept
for neuroinflammatory disorders.
Edward Tobinick MD. Drug
Discovery Today 2009 Feb; 14(3-4):168-77.The videos above are interviews discussing
and documenting the clinical response to initiation of anti-TNF
treatment (perispinal etanercept) at the INR. For
the published results please see Tobinick E, Gross H, Weinberger
A, Cohen H., TNF-alpha Modulation for Treatment of Alzheimer's
Disease: A 6-Month Pilot Study MedGenMed 2006; 8(2) :25;
Tobinick E., Perispinal etanercept for treatment of Alzheimer's
disease, Current Alzheimer Research 2007 Dec; 4(5):550-2;
Tobinick E, Gross H., Rapid improvement in verbal fluency
and aphasia following perispinal etanercept in Alzheimer's disease,
BMC Neurology 2008; 8:27; and Tobinick E., Perispinal
etanercept for neuroinflammatory disorders, Drug Discovery
Today 2009 Feb; 14(3-4):168-77.Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California
90095
Video2